Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.14M | 72.18M | 68.28M | 69.07M | 61.10M |
| Total Depreciation and Amortization | 54.60M | 53.49M | 54.40M | 47.60M | 45.95M |
| Total Amortization of Deferred Charges | 3.13M | 3.13M | 1.58M | 6.59M | 6.59M |
| Total Other Non-Cash Items | 7.32M | 6.34M | 2.37M | -9.69M | -5.15M |
| Change in Net Operating Assets | -18.64M | -9.30M | -10.56M | -2.67M | -12.14M |
| Cash from Operations | 119.56M | 125.84M | 116.07M | 110.89M | 96.35M |
| Capital Expenditure | -27.66M | -28.32M | -36.12M | -28.47M | -29.35M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.90M | 1.32M | -70.07M | -85.09M | -84.30M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 488.00K | -3.28M | 1.42M | -16.50M | -16.47M |
| Cash from Investing | -24.28M | -30.28M | -104.77M | -130.05M | -130.12M |
| Total Debt Issued | 44.79M | -12.97M | 72.45M | 92.69M | 92.69M |
| Total Debt Repaid | -111.89M | -57.64M | -57.04M | -63.78M | -51.15M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -4.28M | -1.28M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.65M | -9.65M | -9.65M | -759.00K | -759.00K |
| Cash from Financing | -81.03M | -81.54M | 5.76M | 28.16M | 40.78M |
| Foreign Exchange rate Adjustments | 2.65M | 394.00K | -3.55M | 1.85M | -1.07M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.90M | 14.41M | 13.51M | 10.85M | 5.94M |